ΑLBENDAZOLE 300/ANAFASIS, δισκία 300 mg/tab για πρόβατα
ΑLBENDAZOLE 300/ANAFASIS, δισκία 300 mg/tab για πρόβατα
Authorised
This information is not available for this product.
Product identification
Medicine name:
ΑLBENDAZOLE 300/ANAFASIS, δισκία 300 mg/tab για πρόβατα
Active substance:
This information is not available for this product.
Target species:
-
Sheep
Route of administration:
-
Oral use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Sheep
-
Meat and offal10dayμετά από την τελευταία χορήγηση
-
Milk5dayμετά από την τελευταία χορήγηση
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC11
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Uplab Pharmaceutical Company Ltd.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 95613/20-10-2021/K-0160301
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 19/09/2023
Updated on: 21/09/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 19/09/2023
Updated on: 21/09/2023
How useful was this page?:
